EOLS

Evolus Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 2/10
Evolus sales and earnings growth
EOLS Growth
Good
  • Revenue Y/Y↑ 7.08%
  • EPS Y/Y↑ 23.86%
  • FCF Y/Y↓ -55.23%
Evolus gross and profit margin trends
EOLS Profitability
Good
  • Gross margin ↑ 66.10%
  • EPS margin↓ -14.40%
  • ROIC 5Y↓ -30.30%
Evolus net debt vs free cash flow
EOLS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 2.6
  • Interest coverage↓ -1.2

Evolus stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks